← all works
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.
Abstract
T his is the second edition (version 1.2) of this document, which was originally adapted from Clinical management of severe acute respiratory infection when MERS-CoV infection is suspected (WHO, 2019).
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Pediatria i Medycyna Rodzinna
- Topic
- COVID-19 Clinical Research Studies
- Field
- Medicine
- Canadian institutions
- —
- Funders
- NIH Clinical CenterChina-Japan Friendship HospitalSamsungKing Saud bin Abdulaziz University for Health ScienceCapital Medical UniversityUniversidade de São PauloChinese University of Hong KongUniversity of TorontoSungkyunkwan UniversityKhon Kaen UniversityFudan UniversityNational Center for Global Health and MedicineBC Children's HospitalPublic Health EnglandCenters for Disease Control and PreventionUNICEF
- Keywords
- MedicineInterimCoronavirus disease 2019 (COVID-19)Respiratory systemIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDiseaseInternal medicineVirologyInfectious disease (medical specialty)Outbreak
- Has abstract in OpenAlex
- yes